FLUCONAZOLE 150mg. IP

An azole antifungal medication that has broad-spectrum fungistatic activity against yeasts and fungi. (F Montero-Gei, 1993) Disrupts the synthesis of ergosterol, which is an essential building block in fungal cell membranes. (C. Charlier, 2006) Provides over 90% clinical cure or improvement for cutaneous mycosis including tinea, pityriasis, cryptococcosis, and candidiasis. (D Debruyne, 1997) A first-line treatment option in several cases of invasive candidiasis. (C Charlier, 2006) An efficacious and safe regimen in the treatment of tinea corporis and cruris. (Stary A., 1998) An effective treatment against a wide range of fungi and has a favorable pharmacokinetic profile. (J H Dobloug, 1992) A promising therapy for the treatment of cryptococcal meningitis. (E M Bailey, 1990) An important antifungal drug in the management of fungal infections in patients with immune deficiencies. (K L Goa, 1995) A highly effective agent in urinary tract infections caused by Candida species and other fungi. (M S Saag, 1988) A mycological effective drug for the treatment of tinea corporis and tinea cruris. (J Faergemann, 1997) A useful antifungal agent for the treatment of systemic deep-seated mycoses. (Hideo Ikemoto, 1989) As effective as posaconazole, and itraconazole in preventing invasive fungal infections in pediatric patients. (M Döring, 2015)